AIDS Healthcare Foundation Suppports the HCV Coalition for the Cure

"The unfettered greed that drives the lack of cooperation between pharmaceutical giants Gilead and Bristol-Myers Squibb comes at the unacceptably high price of the health and well-being of Hepatitis C patients," said AHF President Michael Weinstein. "The withholding of effective treatment for patients suffering from this illness to instead boost shareholder returns has gone on for too long, and as the new year begins, so must this travesty end." http://takeaction.aidshealth.org/site/MessageViewer?em_id=13621.0